Research center
At Orbis, research and evidence are fundamental parts of our mission to build strong and stable eye care systems that put treatment and prevention within reach. What we learn is used to inform our evidence-based approach to build long-term sight-saving programs. Our findings also have implications that can strengthen outcomes in the eye care sector
ORBIS RESEARCH SHOWS THE POWER OF AI FOR IMPROVING PRODUCTIVITY OF EYE TEAMS
Published in Nature, the peer-reviewed study is the first to demonstrate significant improvements in the productivity of medical professionals when using autonomous artificial intelligence (AI) to test for diabetic eye diseases.
FIRST-OF-ITS-KIND ORBIS RESEARCH SHOWS BENEFITS OF AI TO DIAGNOSE EYE DISEASE IN CHILDREN
A new Orbis study find AI-led screenings are a highly successful tool in detecting diabetic retinopathy in kids living with diabetes. Until now, very few studies with children and young adults existed.
ORBIS RESEARCH REVEALS LINK BETWEEN VISION AND MENTAL HEALTH
A new Orbis study into mental health shows that vision impairment has a significant impact on a child's mental health. This corroborated a previous Orbis study from 2022 that found higher rates of depression and anxiety were diagnosed in vision-impaired children.
RESEARCH: TWO ORIGINAL ORBIS STUDIES SHOW BENEFITS OF AI FOR RURAL EYE CARE
Two peer-reviewed Orbis studies in the British Journal of Ophthalmology and Ophthalmology Science show the potential for artificial intelligence (AI) to transform eye care in hard-to-reach communities.
FIRST-OF-ITS-KIND STUDY FINDS ARTIFICIAL INTELLIGENCE SCREENINGS IMPROVE EYE CARE ACCESS IN SUB-SAHARAN AFRICA
The new research focuses on diabetic retinopathy in Rwanda, where associated vision complications from diabetes are growing.
